Breast and prostate cancer patients differ significantly in their serum Thymidine kinase 1 (TK1) specific activities compared with those hematological malignancies and blood donors: implications of using serum TK1 as a biomarker
Crossref DOI link: https://doi.org/10.1186/s12885-015-1073-8
Published Online: 2015-02-18
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Jagarlamudi, Kiran Kumar
Hansson, Lars Olof
Eriksson, Staffan
License valid from 2015-02-18